A biotech company reports that an experimental treatment elongated its CEO’s telomeres.
January 8, 2001|
Approximately 1.6 million single nucleotide polymorphisms (SNPs) have been identified and deposited in public databases, but more are always needed for studies of other species and identification of mutations in candidate disease genes. In the January Nature Biotechnology, Nakatani et al. outline a new method for SNP identification using capture by a mismatch-specific ligand followed by surface plasmon resonance (SPR; Nat Biotechnol 2001, 19:51-55). The ligand, a dimeric naphthyridine, intercala